Alaunos Therapeutics (TCRT)
(Delayed Data from NSDQ)
$1.32 USD
+0.16 (13.79%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.33 +0.01 (0.76%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMKey Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
04/02/2024
Time: -- |
12/2023 | $-0.60 | 0.00% |
Earnings Summary
For their last quarter, Alaunos Therapeutics (TCRT) reported earnings of -$0.60 per share, missing the Zacks Consensus Estimate of -$0.45 per share. This reflects a negative earnings surprise of 33.33%. Look out for TCRT's next earnings release expected on April 02, 2024. For the next earning release, we expect the company to report earnings of -$0.60 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for TCRT
Merck (MRK), Eisai to End Keytruda-Lenvima Combo Cancer Study
TCRT: What are Zacks experts saying now?
Zacks Private Portfolio Services